A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19

Clinical trial NCT04469621 · COMPLETED

Trial details

NCT number: NCT04469621
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Corona Virus Infection

Start date: 2020-07-17
Primary completion: 2020-10-23
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.